William R. Marrs, Ph.D.
Institution:
University of Washington, Seattle, Seattle, WAArea:
Cannabinoid signaling and neuroinflammationGoogle:
"William Marrs"Mean distance: 15.48 (cluster 6) | S | N | B | C | P |
Parents
Sign in to add mentorNephi Stella | grad student | 2011 | University of Washington | |
(The Serine Hydrolase ABHD6 Regulates Endocannabinoid Signaling.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Naydenov AV, Horne EA, Cheah CS, et al. (2014) ABHD6 blockade exerts antiepileptic activity in PTZ-induced seizures and in spontaneous seizures in R6/2 mice. Neuron. 83: 361-71 |
Horne EA, Coy J, Swinney K, et al. (2013) Downregulation of cannabinoid receptor 1 from neuropeptide Y interneurons in the basal ganglia of patients with Huntington's disease and mouse models. The European Journal of Neuroscience. 37: 429-40 |
Marrs WR, Horne EA, Ortega-Gutierrez S, et al. (2011) Dual inhibition of alpha/beta-hydrolase domain 6 and fatty acid amide hydrolase increases endocannabinoid levels in neurons. The Journal of Biological Chemistry. 286: 28723-8 |
Marrs WR, Blankman JL, Horne EA, et al. (2010) The serine hydrolase ABHD6 controls the accumulation and efficacy of 2-AG at cannabinoid receptors. Nature Neuroscience. 13: 951-7 |
Cudaback E, Marrs W, Moeller T, et al. (2010) The expression level of CB1 and CB2 receptors determines their efficacy at inducing apoptosis in astrocytomas. Plos One. 5: e8702 |
Marrs W, Stella N. (2009) Measuring endocannabinoid hydrolysis: refining our tools and understanding. The Aaps Journal. 11: 307-11 |
Marrs W, Stella N. (2007) 2-AG + 2 new players = forecast for therapeutic advances. Chemistry & Biology. 14: 1309-11 |
Marrs W, Kuperman J, Avedian T, et al. (2005) Alpha-2 adrenoceptor activation inhibits phencyclidine-induced deficits of spatial working memory in rats. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 30: 1500-10 |